CureBay raises Rs 62 crore from Elevar, others
The fund will enable the health-tech innovator to continue creating access to high quality and affordable healthcare in under-served locations, build an intelligent and robust health data platform and also to hire over 200 professionals including data scientists, healthcare experts, the startup said in a statement on Saturday.
CureBay, a startup focused on solving primary healthcare in remote locations, has raised Rs 62 crore in a series-A funding round led by Elevar Equity, existing investor as well as its founders and leadership team members.
The fund will enable the health-tech innovator to continue creating access to high quality and affordable healthcare in under-served locations, build an intelligent and robust health data platform and also to hire over 200 professionals including data scientists, healthcare experts, the startup said in a statement on Saturday.
CureBay is also planning to expand its count of clinics from the existing 90 to over 200 across Odisha, Chhattisgarh and also enter Jharkhand, said its founder and chief executive Priyadarshi Mohapatra.
Jyotsna Krishnan, managing partner at Elevar Equity, said, rural households aspire to have affordable access to healthcare services.
CureBay's blended distribution model, augmented with technology, is well-positioned to address this gap wherein millions of customers in medically under-served locations are eager to pay for timely, quality healthcare.
Founded in 2021, CureBay has connected over 100,000 patients in under-served areas with healthcare providers through its tech-based model.
Currently it has over 90 clinics, covering close to 32,000 villages in Odisha and Chhattisgarh.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Top 5 mid cap mutual funds with best SIP returns in 1 year: See how Rs 25,000 monthly investment has grown in each scheme
Exclusive: Sebi reviews authorised person regulations; discusses minimum qualification, NISM certification and deposit amount criteria
SIP Investment: Can Rs 70/day savings help you build Rs 6 crore corpus? Understand calculations for 10, 20, 30, and 40 years at 13%, 14%, and 15% return
Stocks To Buy For 2 Weeks: Axis Direct recommends buying these stocks for 5-15 day; check targets, stop losses
04:10 PM IST